908 Devices (MASS) Cash & Current Investments (2020 - 2026)
908 Devices' (MASS) quarterly Cash & Current Investments came in at $111.7 million in Q1 2026, down 10.11% year-on-year from $124.3 million in Q1 2025, and down 1.09% on a QoQ basis from $113.0 million in Q4 2025.
908 Devices (MASS) Cash & Current Investments (2020 - 2026) Analysis & Trends
908 Devices (MASS) has 7 years of Cash & Current Investments data on file, last reported at $111.7 million in Q1 2026.
- On a quarterly basis, Cash & Current Investments fell 10.11% year-over-year to $111.7 million in Q1 2026; TTM through Mar 2026 was $111.7 million, a 10.11% decrease from a year earlier, with the FY2025 full-year figure at $113.0 million, up 63.91% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $111.7 million, down from $113.0 million in the prior quarter.
- Over the last five years, Cash & Current Investments for MASS reached as high as $223.1 million in Q1 2022 and fell as low as $68.9 million in Q4 2024.
- Historically, Cash & Current Investments has averaged $138.7 million across 5 years, with a median of $134.2 million in 2024.
- Across the five-year window, Cash & Current Investments tumbled 52.69% in 2024 and surged 63.91% in 2025, its largest moves.
- Year by year, Cash & Current Investments stood at $188.4 million in 2022, then decreased by 22.68% to $145.7 million in 2023, then tumbled by 52.69% to $68.9 million in 2024, then jumped by 63.91% to $113.0 million in 2025, then slipped by 1.09% to $111.7 million in 2026.
- Per Business Quant data, the three most recent Cash & Current Investments figures were $111.7 million in Q1 2026, $113.0 million in Q4 2025, and $112.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.59 Bn | 176.29 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 129.07 Bn | 126.19 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 108.58 Bn | 99.36 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 68.64 Bn | 67.19 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 48.38 Bn | 44.71 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | 1.12 Bn |
| 7 | GE HealthCare Technologies | 28.13 Bn | 25.84 Bn | 1.98 Bn | 2.29 Bn |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - | 577.00 Mn |
| 9 | Koninklijke Philips | 24.27 Bn | 21.15 Bn | 2.07 Bn | 3.12 Bn |
| 10 | 908 Devices | 259.20 Mn | 147.46 Mn | 6.88 Mn | 111.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 111.74 Mn |
| Dec 31, 2025 | 112.97 Mn |
| Sep 30, 2025 | 112.05 Mn |
| Jun 30, 2025 | 118.58 Mn |
| Mar 31, 2025 | 124.32 Mn |
| Dec 31, 2024 | 68.92 Mn |
| Sep 30, 2024 | 71.69 Mn |
| Jun 30, 2024 | 77.38 Mn |
| Mar 31, 2024 | 134.20 Mn |
| Dec 31, 2023 | 145.68 Mn |
| Sep 30, 2023 | 147.90 Mn |
| Jun 30, 2023 | 152.69 Mn |
| Mar 31, 2023 | 161.21 Mn |
| Dec 31, 2022 | 188.42 Mn |
| Sep 30, 2022 | 193.70 Mn |
| Jun 30, 2022 | 212.99 Mn |
| Mar 31, 2022 | 223.12 Mn |
| Dec 31, 2021 | 224.07 Mn |
| Sep 30, 2021 | 138.82 Mn |
| Jun 30, 2021 | 141.31 Mn |